Atlas Trials

Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Clinical trial NCT04798222 · COMPLETED

Trial details

NCT number
NCT04798222
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2021-06-29
Primary completion
2021-09-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.